新闻国内: 用于罕见病治疗的艾美赛珠单抗注射液获批上市

新闻国内 新闻国内

用于罕见病治疗的艾美赛珠单抗注射液获批上市 Dec 4th 2018, 17:09, by www.qq.com 中新网12月4日电据国家药品监督管理局网站消息，近日，国家药品监督管理局批准艾美赛珠单抗注射液进口注册申请，用于治疗存在凝血因子Ⅷ抑制物的A型血友病患者。　　中新社发张斌摄A型血友病是由于X染色体连锁的凝血因子Ⅷ缺乏、凝血功能异常引起的隐性遗传性出血性疾病。患者血液不能正常凝固，易出现不受控和频繁的持续

You are receiving this email because you subscribed to this feed at blogtrottr.com. By using Blogtrottr, you agree to our policies, terms and conditions. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions.